Spotlight Story

Robyn Jimenez
Genomics as a powerful and informative tool to investigate a human endocrine disease.

Image of Robyn Jimenez

Robyn Jimenez is a genetics Ph.D. candidate, working with Dr. Martin Privalsky in the Microbiology and Molecular Genetics Department. She earned my BS in biochemistry and molecular biology from UC Davis in 2010. Her background and experience range from developing markers to detect fungus in agricultural crops to constructing viral vectors for mammalian cell culture. Before entering the doctoral program, JimenezI worked at the UC Davis Bohart Museum of Entomology.

What is important about your research—and where do you hope to take it?

My research focuses on a human endocrine disease, resistance to thyroid hormone (RTH), caused by defects in thyroid hormone receptors (TRs). Endocrine disorders often lead to metabolic diseases, diabetes and cancer. My project takes a broad look at individuals who do not respond to thyroid hormone due to mutations in TRs, and explores the consequential effects on gene expression that ultimately result in disease manifestation.

What are you most passionate about in your work?

I decided to pursue a doctorate in genetics because the explosion of “omics” technologies is quickly advancing biological science from bench to bedside. My two greatest passions—genetics and human health—culminate in my research. With these objectives in mind, I have designed my thesis project to use genomics as a powerful and informative tool to investigate a human endocrine disease.

How will the Business Development Fellows program help you change the world?

Ph.D.s. need flexibility and skill to deal with scientific and business/managerial aspects when working in industry. I look forward to working with other graduate students from a diverse set of backgrounds to understand how commercialized science requires and uses various skills and knowledge. I want to learn what challenges lay ahead in small technology startups, and how to translate a solid, scientific idea into a marketable service or product.

Commands

Twitter Feed

Loading tweets...

Spotlight Story

Andrew Barkett Finds Innovative Ways to Fuel Entrepreneurship
Named First-ever Chief Technology Officer for Republican National Committee

Image of Andrew Barkett Finds Innovative Ways to Fuel Entrepreneurship

UPDATE: Andrew Barkett is leaving his post as senior engineer at Facebook to bring his decade of experience in Silicon Valley to become the first-ever chief technology officer for the Republican National Committee.The June 4 announcement has stirred a whirlwind of media coverage, including the Huffington Post and Washington Post.Bark

Spotlight Story

MBA Student Consultants Make an IMPACT
Projects Put Business Needs Front and Center

Image of MBA Student Consultants Make an IMPACT

Agilent Technologies’ Electronic Measurement Group is a $3.6 billion business that over the past decade has seen a dramatic shift in its customer base from U.S., and Western European customers to predominantly Asia-based customers. Today, the majority of the division’s revenues are generated outside of the U.S., with an increasing concentration in China.

Spotlight Story

UC Davis Part-Time MBA in Top 8%, Full-Time MBA in Top 9%
U.S. News & World Report’s latest rankings: This marks the 19th consecutive year our MBA program has been ranked among the best in the nation.

Image of  UC Davis Part-Time MBA in Top 8%, Full-Time MBA in Top 9%

(Davis, CA) — The UC Davis Graduate School of Management’s full-time MBA program has been ranked among the top six percent of AACSB International-accredited programs nationwide, according to U.S. News & World Report’s latest graduate business school rankings released today.

Spotlight Story

Mark Otero MBA 07 Builds Sacramento’s Coolest Company
The secret of social gaming mogul Mark Otero’s success is taking things to the extreme

Image of Mark Otero MBA 07 Builds Sacramento’s Coolest Company

The secret of Midtown Sacramento’s Facebook gaming mogul Mark Otero’s success is taking things to the extreme.